Lifestyle Delivery System Inc. Announces Equipment Design Modifications to Increase Production Capabilities & Sponsors Marijuana Debate

 
 

Vancouver, British Columbia, Canada, August 25, 2016, Lifestyle Delivery Systems Inc. (CSE: LDS, OTCQB: LDSYF, and XETR: LD6) (“LDS” or the “Company”) is pleased to announce that this week the Company will complete the equipment design modifications necessary to increase production capabilities while, simultaneously, reducing electrical requirements.

LDS, in the evolutionary process of improving its manufacturing capabilities, is completing modifications to
modifications will benefit the production of CannaStrips by decreasing the actual footprint of the equipment by over 20% while increasing the production speed by as much as 25%. These modifications will allow for the production of CannaStrips to be manufactured more efficiently in a much smaller area, making it suitable for production in a modular facility. Brad Eckenweiler, the Company’s CEO, enthusiastically states, “We are very pleased with the results from our team’s efforts in the continuing development of our manufacturing process. The intention was to reduce our operational size while improving our capabilities. I am proud to say we have accomplished all of these objectives and the Company will certainly benefit from these accomplishments.”

The Company is one of the sponsors of “The End of Opiates”, an event to benefit Dr. Piomelli and his team’s research at University of California, Irvine. LDS would like to encourage all of our shareholders and those parties interested in the medical marijuana debate to attend. This is your opportunity to be one of the first to learn about the incredible breakthroughs that could put an end to the opiate epidemic we face today. Dinner and drinks will be provided, along with engaging discussions from those at the forefront of this pursuit. All net proceeds directly benefit cannabinoid and pain research at UC Irvine. The evening begins at 7:00 PM at Avenue of the Arts Hotel in Costa Mesa, CA, with a welcome from Justin S. Beck, CEO of Cultivation Technologies, Inc., followed by:

· “The Future of Pain Management” presented by Dr. Daniele Piomelli
· “Specific Research Paths” presented by Dr. Guillermo Moreno Sanz
· “Cannabis Therapeutics & the FDA” presented by Stephen Goldner
· “Pain & Opiate Addiction” presentations by patients

Patients, physicians, scientists, industry leaders, philanthropists, and students are all invited to attend this engaging and inspirational event. Admission tickets and additional donations can be made at: https://endofopiates.eventbrite.com. If you are unable to attend but would like to contribute (in any amount) to this worthy cause, please click on “Tickets” and then select the “I want to donate” option.

Lifestyle Delivery Systems Inc. Suite 810, 789 W. Pender St.
Vancouver BC, V6C 1H2
T: (866) 347-5058   F: (604) 648-0517

About Lifestyle Delivery Systems Inc.

The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking but also a new way to accurately meter the dosage and assure the purity of the product. From start to finish, the production process tests for quality and composition of all the ingredients used in each and every strip, resulting in a delivery system that is safe, consistent and effective.

On behalf of the board of directors of Lifestyle Delivery Systems Inc.

Brad Eckenweiler CEO & Director

FOR MORE INFORMATION, PLEASE CONTACT:

investor.relations@lifestyledeliverysystem.com

1-866-347-5058

Cautionary Disclaimer Statement:

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with environmental and governmental regulations. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.